In the BioHarmony Drug Report Database

"Preview" Icon

Mitoxantrone

Novantrone (mitoxantrone) is a small molecule pharmaceutical. Mitoxantrone was first approved as Novantrone on 1987-12-23. It is used to treat breast neoplasms, lymphoma, multiple sclerosis, myeloid leukemia acute, and pain amongst others in the USA. It is known to target DNA topoisomerase 2-alpha and DNA topoisomerase 2-beta.

 

Trade Name

 

Novantrone
 

Common Name

 

mitoxantrone
 

ChEMBL ID

 

CHEMBL58
 

Indication

 

breast neoplasms, lymphoma, multiple sclerosis, myeloid leukemia acute, pain, prostatic neoplasms, sarcoma
 

Drug Class

 

Antineoplastics, anthraquinone derivatives

Image (chem structure or protein)

Mitoxantrone structure rendering